Genenta to Present at Upcoming Scientific Congresses ASGCT, BTM, ASCO and EHA

Last Updated on May 13, 2022 by GlobeNewsWire

MILAN, Italy and NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) — Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the development of hematopoietic stem progenitor cell immuno-gene therapy for cancer, will be presenting at several upcoming scientific congresses in May and June.